Eficacia y seguridad de la enoxaparina en reemplazos articulares de cadera o rodilla. Una revisión sistemática de la literatura

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest., 133, 381S, 10.1378/chest.08-0656 Planès, 1991, Prevention of deep vein thrombosis after total hip replacement. The effect of low-molecular-weight heparin with spinal and general anaesthesia, J Bone Joint Surg Br., 73, 418, 10.1302/0301-620X.73B3.1670442 Geerts, 2001, Prevention of venous thromboembolism, Chest., 119, 132S, 10.1378/chest.119.1_suppl.132S 1999, Thromboprophylaxis in hip fracture surgery: a pilot study comparing danaparoid, enoxaparin and dalteparin, Haemostasis., 29, 310 Eriksson, 2001, Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery, N Engl J Med., 345, 1298, 10.1056/NEJMoa011100 Lassen, 2007, The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement, J Thromb Haemost., 5, 2368, 10.1111/j.1538-7836.2007.02764.x Eriksson, 2005, A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial, J Thromb Haemost., 3, 103, 10.1111/j.1538-7836.2004.01100.x Eriksson, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty, N Engl J Med., 358, 2765, 10.1056/NEJMoa0800374 Turpie, 2011, Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies, Thromb Haemost., 105, 444, 10.1160/TH10-09-0601 Kakkar, 2008, Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial, Lancet., 372, 31, 10.1016/S0140-6736(08)60880-6 Lassen, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, N Engl J Med., 358, 2776, 10.1056/NEJMoa076016 Dahl, 2010, A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty, J Thromb Haemost., 8, 1966, 10.1111/j.1538-7836.2010.03965.x Eriksson, 2003, Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement, Thromb Haemost., 89, 288, 10.1055/s-0037-1613445 Eriksson, 2003, The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study, J Thromb Haemost., 1, 2490, 10.1111/j.1538-7836.2003.00494.x Raskob, 2012, Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials, J Bone Joint Surg Br., 94, 257, 10.1302/0301-620X.94B2.27850 Wolowacz, 2009, Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty, A meta-analysis. Thromb Haemost., 101, 77, 10.1160/TH08-07-0493 Turpie, 2002, Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies, Arch Intern Med., 162, 1833, 10.1001/archinte.162.16.1833 Aristizábal, 2013, Rivaroxaban frente a heparinas de bajo peso molecular para la prevención de la tromboembolia venosa posterior al reemplazo total de cadera o rodilla: revisión sistemática de la literatura y metaanálisisis, Iatreia., 26, 136